Glycemic control in subjects with type 2 diabetes treated with... | Download Scientific Diagram
Longacting exenatide in diabetes: DURATION-3 - The Lancet
Exenatide once weekly in type 2 diabetes - The Lancet
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study - The Lancet
Exenatide Treatment Alone Improves β-Cell Function in a Canine Model of Pre- Diabetes | PLOS ONE
BYDUREON® Pen, a Treatment Option for Adults with Type 2 Diabetes, Now Available in Pharmacies | Business Wire
Depot-Exenatid in neuem Fertigpen | PZ – Pharmazeutische Zeitung
Exenatid - Anwendung, Wirkung, Nebenwirkungen | Gelbe Liste
Exenatide: Uses, Interactions, Mechanism of Action | DrugBank Online
Exenatid – Inkretin-Mimetikum zur Behandlung des Diabetes mellitus Typ 2 - 10 - 2005 - Heftarchiv - AMT
The metabolic effects of adding exenatide to basal insulin therapy when targeting remission in early type 2 diabetes in a randomized clinical trial | Nature Communications
Exenatide Diabetes Drug Molecule. 3D Rendering. Molecular Surface Cartoon Representation. Stock Illustration - Illustration of type, molecule: 187043350
Spinal cord-wide structural disruption in type 2 diabetes rescued by exenatide "a glucagon-like peptide-1 analogue" via down-regulating inflammatory, oxidative stress and apoptotic signaling pathways - ScienceDirect
Typ-II-Diabetes: Exenatide ist erstes Inkretin-Mimetikum
Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study | SpringerLink
Exendin-4 (Exenatide) - CPC Scientific
Exenatide OK'd for Type 2 Diabetes in Adolescents | MedPage Today